In today's digital age, brands are facing increasing pressure to be transparent. Recent incidents, like the Air India crash ...

Key Points President Trump has threatened to levy tariffs of up to 200% on pharmaceutical imports.Lilly's margins could be negatively affected if the company absorbs the higher costs.However, any ...

An investigation by Democratic senators has raised concerns about conflicts of interest in telehealth companies' ties to pharmaceutical companies Pfizer and Eli Lilly.

After a nine-month investigation into direct-to-consumer telehealth platforms launched by Eli Lilly and Pfizer, a group of ...

Henry Liu, former director of the Federal Trade Commission’s Bureau of Competition under the Biden administration, has ...

Eli Lilly stock currently trades below its 50-week average, offering a strong entry point despite continued dominance in weight-loss and diabetes drugs. With a 32% revenue increase in 2024 and ...

Shares of Eli Lilly & Co. LLY slid 2.47% to $775.45 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.52% to 6,173.07 ...

Meanwhile, Lilly is notching win after win. Eli Lilly's position in the weight management market makes its stock attractive, considering how fast this area is projected to grow in the coming years.

In France, for example, Tesla will now be fined for every day it continues its "deceptive marketing practices," Politico reports.

Wall Street remains bullish on Eli Lilly, forecasting potential gains despite the reimbursement snub. Eli Lilly reported a 45% revenue surge, thanks largely to the skyrocketing sales of Mounjaro and ...